In the Media

Researchers with the Regenstrief Institute and Indiana University School of Medicine are taking a look at the prevalence of lingering COVID-19 symptoms.

Should providers use clinical texts for nonurgent FYI notifications and thank-yous, or do those just waste hospitalists’ time?

US health regulators are warning about the dangers of a new TikTok challenge.

IU Health has opened a $10 million state-of-the-art out-patient family medicine center.

Dr. Connor Parker is a third-year resident at Indiana University School of Medicine who sees patients at Methodist Hospital and University Hospital.

A newly approved pill for colonoscopy prep could sway more people to get screened.

This drug can help treat pain from conditions like fibromyalgia and diabetic neuropathy.

The grant will fund both the analysis of data from electronic health records and follow individuals over time to detect trends related to what is known as “long COVID.”

Indiana University and the Regenstrief Institute have partnered to develop one of the first population-based surveillance systems for long COVID.

The Regenstrief Institute in Indianapolis and the schools of medicine and public health at Indiana University have received a grant to study the long-term effects of COVID-19.

IU School of Medicine in Indianapolis and the IU School of Public Health in Bloomington are partnering with the Regenstrief Institute to study long COVID.

Indiana partners say they will develop one of the first comprehensive, population-based surveillance systems for long COVID in the U.S.